Sílvia Capilla

1.0k total citations
18 papers, 330 citations indexed

About

Sílvia Capilla is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Sílvia Capilla has authored 18 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Sílvia Capilla's work include Respiratory viral infections research (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Sílvia Capilla is often cited by papers focused on Respiratory viral infections research (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Sílvia Capilla collaborates with scholars based in Spain, United States and Sweden. Sílvia Capilla's co-authors include R Gómez-Lus, Pilar Goñi, Francisco Javier Castillo, Arina Clavel, Cristina Seral, Ángel Arias, Marı́a Teresa Llorente, Concepción Montón, Eduard Monsó and Xavier Pomares and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and European Respiratory Journal.

In The Last Decade

Sílvia Capilla

16 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sílvia Capilla Spain 9 154 135 88 80 42 18 330
Damien Mack United Kingdom 8 113 0.7× 42 0.3× 36 0.4× 21 0.3× 8 0.2× 16 266
J. Loutit United States 11 85 0.6× 104 0.8× 58 0.7× 157 2.0× 3 0.1× 16 364
Stéphanie Herwegh France 9 105 0.7× 25 0.2× 72 0.8× 53 0.7× 14 0.3× 14 322
L. Franzin Italy 11 106 0.7× 89 0.7× 58 0.7× 31 0.4× 3 0.1× 21 337
Michio Koide Japan 14 88 0.6× 14 0.1× 216 2.5× 43 0.5× 8 0.2× 59 550
Cirle Alcantara United States 9 216 1.4× 139 1.0× 33 0.4× 20 0.3× 7 0.2× 10 352
Danjiang Dong China 8 105 0.7× 23 0.2× 34 0.4× 14 0.2× 8 0.2× 21 257
Clémence Beauruelle France 11 40 0.3× 12 0.1× 102 1.2× 56 0.7× 18 0.4× 24 225
F. Gourdon France 9 91 0.6× 28 0.2× 22 0.3× 17 0.2× 7 0.2× 17 235
Martina Wade United States 8 46 0.3× 41 0.3× 34 0.4× 22 0.3× 8 0.2× 17 268

Countries citing papers authored by Sílvia Capilla

Since Specialization
Citations

This map shows the geographic impact of Sílvia Capilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sílvia Capilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sílvia Capilla more than expected).

Fields of papers citing papers by Sílvia Capilla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sílvia Capilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sílvia Capilla. The network helps show where Sílvia Capilla may publish in the future.

Co-authorship network of co-authors of Sílvia Capilla

This figure shows the co-authorship network connecting the top 25 collaborators of Sílvia Capilla. A scholar is included among the top collaborators of Sílvia Capilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sílvia Capilla. Sílvia Capilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Mària, Cristina García de la, Sílvia Capilla, Mateu Espasa, et al.. (2025). Is ampicillin plus cephalosporins a therapeutic option for Ampicillin-Susceptible Enterococcus faecium?. Journal of Antimicrobial Chemotherapy. 80(10). 2622–2629.
2.
Pich, Òscar Q., Carme Roca Saumell, Ángela Martínez-Pérez, et al.. (2024). Prevalence and Risk Factors for Colonization by Multidrug-Resistant Microorganisms among Long-Term Travelers and Recently Arrived Migrants. Microorganisms. 12(5). 936–936. 2 indexed citations
3.
Henares, Desirée, Pedro Brotons, Sílvia Capilla, et al.. (2024). Human gut microbiota composition associated with international travels. Travel Medicine and Infectious Disease. 61. 102747–102747. 2 indexed citations
4.
Eynde, Eva Van den, Oriol Gasch, Joan Carles Oliva, et al.. (2021). Corticosteroids and tocilizumab reduce in-hospital mortality in severe COVID-19 pneumonia: a retrospective study in a Spanish hospital. Infectious Diseases. 53(4). 291–302. 20 indexed citations
5.
García-Núñez, Marian, Miguel García González, Xavier Pomares, et al.. (2020). The Respiratory Microbiome in Cystic Fibrosis: Compartment Patterns and Clinical Relationships in Early Stage Disease. Frontiers in Microbiology. 11. 1463–1463. 13 indexed citations
6.
Millares, Laura, Sergi Pascual-Guàrdia, Concepción Montón, et al.. (2019). Relationship between the respiratory microbiome and the severity of airflow limitation, history of exacerbations and circulating eosinophils in COPD patients. BMC Pulmonary Medicine. 19(1). 112–112. 35 indexed citations
7.
García-Núñez, Marian, Miguel Gallego, Concepción Montón, et al.. (2018). The Respiratory Virome in Chronic Obstructive Pulmonary Disease. Future Virology. 13(7). 457–466. 4 indexed citations
8.
Fontanals, D., et al.. (2017). Chorioamnionitis due to Leptotrichia trevisanii. Anaerobe. 49. 18–20. 4 indexed citations
9.
Gallego, Miguel, Xavier Pomares, Sílvia Capilla, et al.. (2016). C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity. International Journal of COPD. Volume 11. 2633–2640. 25 indexed citations
10.
Villamil, Carlos F., Araceli González-Cuevas, David Martí-Garín, et al.. (2016). Usefulness of Urinoculture to Patients With Dementia and Femoral Neck Fracture at Admission to Hospital. Geriatric Orthopaedic Surgery & Rehabilitation. 8(1). 10–13. 5 indexed citations
11.
Millares, Laura, Vicente Pérez‐Brocal, Rafaela Gomes Ferrari, et al.. (2015). Functional Metagenomics of the Bronchial Microbiome in COPD. PLoS ONE. 10(12). e0144448–e0144448. 39 indexed citations
12.
García-Núñez, Marian, Vicente Pérez‐Brocal, Xavier Pomares, et al.. (2014). Bacterial and viral microbiomes in COPD exacerbations of unidentified cause. European Respiratory Journal. 44(Suppl 58). P2534–P2534.
13.
Clavel, Arina, Pilar Goñi, Cristina Seral, et al.. (2007). Correlation between the presence of symptoms and the Giardia duodenalis genotype. European Journal of Clinical Microbiology & Infectious Diseases. 27(1). 81–83. 137 indexed citations
14.
Castillo, Francisco Javier, et al.. (2005). Vigilancia de la evolución de la flora comensal y de las infecciones en pacientes oncológicos con neutropenia sometidos a quimioprofilaxis. Revista española de quimioterapia. Suplemento. 18(1). 32–38. 1 indexed citations
15.
Rubio-Terrés, Carlos, et al.. (2004). In VitroActivity of Telithromycin, Quinupristin/Dalfopristin, Linezolid and Comparator Antimicrobial Agents AgainstStaphylococcus aureusClinical Isolates. Journal of Chemotherapy. 16(3). 230–237. 8 indexed citations
16.
Goñi, Pilar, et al.. (2004). Macrolide resistance phenotypes of commensal viridans group streptococci and Gemella spp. and PCR detection of resistance genes. International Journal of Antimicrobial Agents. 23(6). 582–589. 9 indexed citations
17.
Capilla, Sílvia. (2004). Characterization of the molecular mechanisms of quinolone resistance in Yersinia enterocolitica O:3 clinical isolates. Journal of Antimicrobial Chemotherapy. 53(6). 1068–1071. 18 indexed citations
18.
Capilla, Sílvia, et al.. (2003). Epidemiological Study of Resistance to Nalidixic Acid and Other Antibiotics in Clinical Yersinia enterocolitica O:3 Isolates. Journal of Clinical Microbiology. 41(10). 4876–4878. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Damien Mack Breakdown of academic impact, for papers by J. Loutit Breakdown of academic impact, for papers by Stéphanie Herwegh Breakdown of academic impact, for papers by L. Franzin Breakdown of academic impact, for papers by Michio Koide Breakdown of academic impact, for papers by Cirle Alcantara Breakdown of academic impact, for papers by Danjiang Dong Breakdown of academic impact, for papers by Clémence Beauruelle Breakdown of academic impact, for papers by F. Gourdon Breakdown of academic impact, for papers by Martina Wade
Rankless by CCL
2026